4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017393
CEO and Chairman sold 4,424 shares at $12.01 ($53,132)
- CEO and Chairman acquired 247,117 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2022-03-04 | Grant or award | +247,117 | 1,920,578 | D: show line 1 in the form | ||
| ROBINS CHAD M CEO and Chairman | 2022-03-07 | Sale | −4,424 | $12.01 | $53,132 | 1,916,154 | D: show line 2 in the form |
| Open-market sales · 4,424 sh · avg $12.01 · $53,132 | |||||||
Loading xslF345X03/doc4.xml…